Workflow
Eterna Therapeutics (ERNA)
icon
Search documents
Eterna Therapeutics (ERNA) - 2019 Q3 - Earnings Call Transcript
2019-11-03 08:33
NTN Buzztime, Inc. (NTN) Q3 2019 Earnings Conference Call October 30, 2019 4:30 PM ET Company Participants Kirsten Chapman - LHA, IR Allen Wolff - Interim CEO Sandra Gurrola - SVP of Finance Conference Call Participants Operator Operator Good afternoon, ladies and gentlemen, and welcome to the NTN Buzztime Third Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the conf ...
Eterna Therapeutics (ERNA) - 2019 Q3 - Quarterly Report
2019-11-01 20:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock NTN NYSE American Emerging growth company [ ] FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 Commission file number 001-11460 NTN Buzztime, Inc. (Exact name of registrant as specified in its charter) 1800 ASTON AVENUE, SUITE 100, CARLSBAD, CALIFO ...
Eterna Therapeutics (ERNA) - 2019 Q2 - Quarterly Report
2019-08-12 20:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock NTN NYSE American FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 Commission file number 001-11460 NTN Buzztime, Inc. (Exact name of registrant as specified in its charter) DELAWARE 31-1103425 (State of incorporation) (I.R.S. Employer Identification No ...
Eterna Therapeutics (ERNA) - 2019 Q2 - Earnings Call Transcript
2019-08-12 14:14
NTN Buzztime, Inc. (NTN) Q2 2019 Earnings Conference Call August 8, 2019 4:30 PM ET Company Participants Kirsten Chapman - LHA, Investor Relations Ram Krishnan - Chief Executive Officer Allen Wolff - Chief Financial Officer Operator Good day, ladies and gentlemen, and welcome to the Q2 2019 NTN Buzztime Inc. Earnings Conference Call. At this time, all participants are in a listen only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructio ...
Eterna Therapeutics (ERNA) - 2019 Q1 - Quarterly Report
2019-05-14 20:40
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock NTN NYSE American FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 Commission file number 001-11460 NTN Buzztime, Inc. (Exact name of registrant as specified in its charter) DELAWARE 31-1103425 (State of incorporation) (I.R.S. Employer Identification N ...
Eterna Therapeutics (ERNA) - 2019 Q1 - Earnings Call Transcript
2019-05-14 01:19
NTN Buzztime, Inc. (NTN) Q1 2019 Results Earnings Conference Call May 13, 2019 4:30 PM ET Company Participants Kirsten Chapman - LHA, IR Ram Krishnan - CEO Allen Wolff - CFO Conference Call Participants Operator Good day, ladies and gentlemen, and welcome to the First Quarter 2019 NTN Buzztime Inc. Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded. I would now like to introduce your host for today's conference, Kirsten Chapman from LHA, Investor Relations. Please g ...
Eterna Therapeutics (ERNA) - 2018 Q4 - Annual Report
2019-03-22 20:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of Each Class Name of Each Exchange on Which Registered Common Stock, $.005 par value NYSE American Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2018 Commission File Number 1-11460 NTN Buzztime, Inc. (Exact name of registrant as specified in its charter) Delaware 31-1103425 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. ...
Eterna Therapeutics (ERNA) - 2018 Q4 - Earnings Call Transcript
2019-03-21 01:54
NTN Buzztime, Inc. (NTN) Q4 2018 Earnings Conference Call March 20, 2019 4:30 PM ET Company Participants Kirsten Chapman - LHA, IR Ram Krishnan - Director & CEO Allen Wolff - EVP & CFO Conference Call Participants William Gibson - Roth Capital Partners Operator Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2018 NTN Buzztime Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to introduce your host for today's conferenc ...